So, I try to be driven by curiosity-- Like, of course I'm going to be driven by curiosity with respect to what happened to me, but sometimes interesting data come out and I'll talk about them in a positive light, even if they don't align with what I practice and do and that's not hypocritical
7.2 Comparing with the novel metabolic target drugs As the FXR-activating function of GLP-1RAs, FXR agonists may have the same effect as GLP-1RAs ( In reducing the risk of major adverse liver outcomes and HCC, large-scale observational studies and meta-analyses have demonstrated that GLP-1RA and SGLT2i exhibit comparable protective effects, with both showing significant superiority over traditional hypoglycemic agents such as DPP-4i and sulfonylureas
Given the 5 to 8 minute plasma half-life, protocols that use subcutaneous injection are working against basic pharmacokinetics
Compounded semaglutide products are not FDA-approved finished drugs and have not been independently evaluated by the FDA for safety, effectiveness, or quality
With our commitment to excellence and dedication to patient care, Dr